Integra LifeSciences Holdings Operating Margin 2010-2025 | IART
Current and historical operating margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current operating profit margin for Integra LifeSciences Holdings as of March 31, 2025 is 11.43%.
| Integra LifeSciences Holdings Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-03-31 | $1.63B | $0.01B | 0.62% |
| 2024-12-31 | $1.61B | $0.03B | 1.80% |
| 2024-09-30 | $1.57B | $0.03B | 1.85% |
| 2024-06-30 | $1.57B | $0.06B | 4.09% |
| 2024-03-31 | $1.53B | $0.08B | 5.23% |
| 2023-12-31 | $1.54B | $0.11B | 7.27% |
| 2023-09-30 | $1.54B | $0.14B | 9.34% |
| 2023-06-30 | $1.55B | $0.18B | 11.78% |
| 2023-03-31 | $1.56B | $0.23B | 14.66% |
| 2022-12-31 | $1.56B | $0.24B | 15.34% |
| 2022-09-30 | $1.57B | $0.23B | 14.62% |
| 2022-06-30 | $1.57B | $0.22B | 14.03% |
| 2022-03-31 | $1.56B | $0.21B | 13.59% |
| 2021-12-31 | $1.54B | $0.20B | 12.77% |
| 2021-09-30 | $1.53B | $0.19B | 12.58% |
| 2021-06-30 | $1.51B | $0.19B | 12.86% |
| 2021-03-31 | $1.38B | $0.16B | 11.32% |
| 2020-12-31 | $1.37B | $0.15B | 11.08% |
| 2020-09-30 | $1.38B | $0.14B | 9.80% |
| 2020-06-30 | $1.39B | $0.06B | 4.04% |
| 2020-03-31 | $1.51B | $0.09B | 5.82% |
| 2019-12-31 | $1.52B | $0.09B | 6.13% |
| 2019-09-30 | $1.51B | $0.09B | 6.04% |
| 2019-06-30 | $1.49B | $0.14B | 9.11% |
| 2019-03-31 | $1.48B | $0.12B | 8.00% |
| 2018-12-31 | $1.47B | $0.11B | 7.61% |
| 2018-09-30 | $1.46B | $0.09B | 5.83% |
| 2018-06-30 | $1.37B | $0.07B | 5.25% |
| 2018-03-31 | $1.29B | $0.06B | 4.74% |
| 2017-12-31 | $1.19B | $0.05B | 3.78% |
| 2017-09-30 | $1.08B | $0.08B | 7.34% |
| 2017-06-30 | $1.05B | $0.10B | 9.36% |
| 2017-03-31 | $1.01B | $0.10B | 10.16% |
| 2016-12-31 | $0.99B | $0.12B | 11.59% |
| 2016-09-30 | $0.98B | $0.10B | 10.03% |
| 2016-06-30 | $0.95B | $0.08B | 8.18% |
| 2016-03-31 | $0.92B | $0.08B | 8.72% |
| 2015-12-31 | $0.88B | $0.08B | 8.95% |
| 2015-09-30 | $0.80B | $0.09B | 10.69% |
| 2015-06-30 | $0.77B | $0.09B | 11.99% |
| 2015-03-31 | $0.79B | $0.08B | 10.19% |
| 2014-12-31 | $0.80B | $0.07B | 8.53% |
| 2014-09-30 | $0.73B | $0.10B | 13.93% |
| 2014-06-30 | $0.74B | $0.05B | 7.16% |
| 2014-03-31 | $0.72B | $0.05B | 6.57% |
| 2013-12-31 | $0.70B | $0.04B | 5.16% |
| 2013-09-30 | $0.83B | $-0.01B | -0.96% |
| 2013-06-30 | $0.83B | $0.04B | 5.20% |
| 2013-03-31 | $0.83B | $0.06B | 6.62% |
| 2012-12-31 | $0.83B | $0.07B | 8.92% |
| 2012-09-30 | $0.82B | $0.06B | 7.68% |
| 2012-06-30 | $0.81B | $0.06B | 7.51% |
| 2012-03-31 | $0.80B | $0.05B | 6.42% |
| 2011-12-31 | $0.78B | $0.06B | 7.05% |
| 2011-09-30 | $0.77B | $0.07B | 9.22% |
| 2011-06-30 | $0.76B | $0.08B | 10.60% |
| 2011-03-31 | $0.74B | $0.10B | 13.09% |
| 2010-12-31 | $0.73B | $0.10B | 13.51% |
| 2010-09-30 | $0.72B | $0.10B | 14.25% |
| 2010-06-30 | $0.71B | $0.10B | 14.12% |
| 2010-03-31 | $0.70B | $0.10B | 14.24% |
| 2009-12-31 | $0.68B | $0.10B | 14.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.865B | $1.611B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.883B | 81.42 |
| Thermo Fisher Scientific (TMO) | United States | $156.566B | 18.94 |
| Edwards Lifesciences (EW) | United States | $44.869B | 29.42 |
| Alcon (ALC) | Switzerland | $43.085B | 29.12 |
| IDEXX Laboratories (IDXX) | United States | $41.386B | 47.56 |
| DexCom (DXCM) | United States | $32.894B | 50.84 |
| IQVIA Holdings (IQV) | United States | $27.789B | 15.56 |
| Mettler-Toledo (MTD) | United States | $24.833B | 29.53 |
| STERIS (STE) | Ireland | $22.191B | 24.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.420B | 0.00 |
| Waters (WAT) | United States | $17.111B | 24.14 |
| Hologic (HOLX) | United States | $14.260B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.443B | 29.62 |
| Penumbra (PEN) | United States | $8.922B | 70.02 |
| Masimo (MASI) | United States | $8.375B | 30.89 |
| Globus Medical (GMED) | United States | $7.627B | 18.17 |
| Glaukos (GKOS) | United States | $5.583B | 0.00 |
| Teleflex (TFX) | United States | $4.908B | 8.10 |
| Integer Holdings (ITGR) | United States | $3.925B | 20.56 |
| TransMedics (TMDX) | United States | $3.717B | 80.79 |
| PROCEPT BioRobotics (PRCT) | United States | $3.228B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.289B | 13.63 |
| Elekta AB (EKTAY) | Sweden | $1.899B | 17.07 |
| Nihon Kohden (NHNKY) | Japan | $1.863B | 21.37 |
| Veracyte (VCYT) | United States | $1.841B | 25.84 |
| Alphatec Holdings (ATEC) | United States | $1.533B | 0.00 |
| Artivion (AORT) | United States | $1.302B | 121.96 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.016B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.984B | 0.00 |
| IRadimed (IRMD) | United States | $0.721B | 36.57 |
| SiBone (SIBN) | United States | $0.708B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.589B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.564B | 12.24 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.519B | 8.07 |
| AxoGen (AXGN) | United States | $0.514B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.416B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.411B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.385B | 8.96 |
| Treace Medical Concepts (TMCI) | United States | $0.355B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.353B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.309B | 0.00 |
| RxSight (RXST) | United States | $0.299B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.258B | 0.00 |
| Neuronetics (STIM) | United States | $0.242B | 0.00 |
| 908 Devices (MASS) | United States | $0.240B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.221B | 13.41 |
| CVRx (CVRX) | United States | $0.209B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.110B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.40 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.11 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.17 |